Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
158.80
-3 (-1.85%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 59.29 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
328.40
51.59
65.96
43.85
283.70
51.97
36.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
328.40
51.59
65.96
43.85
283.70
51.97
36.87
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
1.23
2.05
1.02
0.28
4.35
0.95
5.21
(Increase) / Decrease In Stocks
49.08
-55.45
-78.57
-4.97
26.62
-84.87
-79.59
Employee Cost
10.82
4.21
11.61
10.39
9.59
6.34
10.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
114.49
69.20
106.33
21.80
108.85
101.60
86.87
Selling and Distribution Expenses
108.10
18.67
12.14
4.93
95.70
11.23
2.57
Other Expenses
9.53
8.43
9.85
5.31
9.30
16.31
3.28
Total Expenditure (Excl Depreciation)
293.25
47.11
62.38
37.74
254.41
51.56
28.83
Operating Profit (PBDIT) excl Other Income
35.15
4.48
3.58
6.11
29.29
0.41
8.04
Other Income
1.90
2.38
1.74
1.93
1.76
3.86
0.48
Operating Profit (PBDIT)
37.05
6.86
5.32
8.04
31.05
4.27
8.52
Interest
4.26
4.59
4.54
3.66
3.20
1.37
3.90
Exceptional Items
1.20
1.26
2.69
2.06
2.06
0.00
0.00
Gross Profit (PBDT)
33.99
3.53
3.47
6.44
29.91
2.90
4.62
Depreciation
1.01
1.03
0.98
0.99
0.98
1.34
0.83
Profit Before Tax
32.98
2.49
2.48
5.46
28.94
1.57
3.79
Tax
0.72
2.50
0.87
0.64
0.66
0.63
1.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32.26
-0.01
1.60
4.82
28.28
0.94
2.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.54
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32.26
-0.01
1.60
4.82
28.28
1.48
2.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.26
-0.01
1.60
4.82
28.28
1.48
2.65
Equity Capital
19.00
19.00
19.00
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
16.98
-0.01
0.84
2.54
14.88
0.78
1.39
Diluted Earnings per share
16.98
-0.79
0.89
2.53
14.88
0.42
1.33
Operating Profit Margin (Excl OI)
10.7%
8.68%
5.43%
13.93%
10.32%
0.79%
21.81%
Gross Profit Margin
10.35%
6.84%
5.26%
14.69%
10.54%
5.58%
12.53%
PAT Margin
9.82%
-0.02%
2.43%
10.99%
9.97%
1.81%
7.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 15.76% vs 16.33% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 14.07% vs -15.20% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 20.01% vs -19.86% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 33.12% vs 42.86% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
328.40
299.91
28.49
9.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
328.40
299.91
28.49
9.50%
Raw Material Cost
0.00
69.80
-69.80
-100.00%
Purchase of Finished goods
1.23
234.59
-233.36
-99.48%
(Increase) / Decrease In Stocks
49.08
-32.36
81.44
251.67%
Employee Cost
10.82
4.61
6.21
134.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
114.49
0.00
114.49
Selling and Distribution Expenses
108.10
0.00
108.10
Other Expenses
9.53
3.01
6.52
216.61%
Total Expenditure (Excl Depreciation)
293.25
279.65
13.60
4.86%
Operating Profit (PBDIT) excl Other Income
35.15
20.26
14.89
73.49%
Other Income
1.90
8.71
-6.81
-78.19%
Operating Profit (PBDIT)
37.05
28.97
8.08
27.89%
Interest
4.26
6.69
-2.43
-36.32%
Exceptional Items
1.20
0.00
1.20
Gross Profit (PBDT)
33.99
22.28
11.71
52.56%
Depreciation
1.01
2.11
-1.10
-52.13%
Profit Before Tax
32.98
20.17
12.81
63.51%
Tax
0.72
1.04
-0.32
-30.77%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
32.26
19.13
13.13
68.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
32.26
19.13
13.13
68.64%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
2.95
-2.95
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.26
16.19
16.07
99.26%
Equity Capital
19.00
11.62
7.38
63.51%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.98
13.93
3.05
21.90%
Diluted Earnings per share
16.98
15.38
1.60
10.40%
Operating Profit Margin (Excl OI)
10.70%
6.76%
0.00
3.94%
Gross Profit Margin
10.35%
7.43%
0.00
2.92%
PAT Margin
9.82%
6.38%
0.00
3.44%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 328.40 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 536.56% vs -21.79% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.76% vs 16.33% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 32.26 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3,22,700.00% vs -100.63% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 14.07% vs -15.20% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.15 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 684.60% vs 25.14% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 20.01% vs -19.86% in Jun 2025

Quarterly - Interest
Interest 4.26 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -7.19% vs 1.10% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 33.12% vs 42.86% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.70%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025